| Product Code: ETC6190931 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Sicca syndrome, often associated with conditions like Sjögrens syndrome, leads to dryness in the eyes and mouth. The market for treating Sicca syndrome in Australia is driven by the increasing prevalence of autoimmune diseases and the growing awareness of oral and ocular dryness as symptoms. Treatment typically involves the use of artificial tears, saliva stimulants, and immunosuppressive drugs. Ongoing research into more effective therapies and the development of biologic drugs are expected to fuel the growth of this market.
The Australia Sicca Syndrome Market is experiencing growth due to the rising prevalence of autoimmune disorders, particularly dry eye disease, which is commonly associated with Sicca syndrome. The demand for effective treatments, including immunosuppressive drugs, artificial tears, and newer biologic therapies, is on the rise. There is also a growing focus on personalized medicine, leading to more targeted and efficient treatments. Ongoing clinical research and the development of advanced diagnostic tools are expected to contribute significantly to the market`s expansion.
The market for Sicca syndrome (commonly known as dry eye disease) treatment in Australia faces challenges related to the diverse underlying causes of the condition. Since Sicca syndrome can result from a variety of factors such as aging, autoimmune diseases, medications, and environmental factors, treatment approaches must be tailored, which complicates the development of standardized solutions. Additionally, the high cost of specialized treatments and therapies such as autologous serum eye drops and the limited availability of such treatments in rural areas restrict access to effective management. There is also the challenge of patient non-compliance due to the chronic nature of the disease, as consistent treatment is often required to manage symptoms over time.
With an aging population and increased awareness of autoimmune disorders, there are opportunities to invest in diagnostic tools, immunomodulatory drug development, and biologics targeting sicca syndrome. Telehealth and remote patient management tools also hold promise in this niche.
The government addresses rare autoimmune conditions like Sicca syndrome through Medicare Benefits Schedule (MBS) support for rheumatological consultations and diagnostic tests. Additionally, policies from the National Strategic Action Plan for Rare Diseases encourage early diagnosis and integrated care, while fostering clinical research and data sharing to improve long-term treatment outcomes.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Sicca Syndrome Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Sicca Syndrome Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Sicca Syndrome Market - Industry Life Cycle |
3.4 Australia Sicca Syndrome Market - Porter's Five Forces |
3.5 Australia Sicca Syndrome Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Australia Sicca Syndrome Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.7 Australia Sicca Syndrome Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.8 Australia Sicca Syndrome Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Australia Sicca Syndrome Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Australia Sicca Syndrome Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Australia Sicca Syndrome Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of autoimmune diseases in Australia |
4.2.2 Growing awareness about sicca syndrome among healthcare professionals and patients |
4.2.3 Advancements in diagnostic technologies for sicca syndrome |
4.3 Market Restraints |
4.3.1 High cost of treatment for sicca syndrome |
4.3.2 Limited availability of approved medications for sicca syndrome in Australia |
5 Australia Sicca Syndrome Market Trends |
6 Australia Sicca Syndrome Market, By Types |
6.1 Australia Sicca Syndrome Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Sicca Syndrome Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Australia Sicca Syndrome Market Revenues & Volume, By Primary Sicca/Sjogren Syndrome, 2021- 2031F |
6.1.4 Australia Sicca Syndrome Market Revenues & Volume, By Secondary Sicca/Sjogren Syndrome, 2021- 2031F |
6.1.5 Australia Sicca Syndrome Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Australia Sicca Syndrome Market, By Diagnosis |
6.2.1 Overview and Analysis |
6.2.2 Australia Sicca Syndrome Market Revenues & Volume, By Blood Tests, 2021- 2031F |
6.2.3 Australia Sicca Syndrome Market Revenues & Volume, By Eye Tests, 2021- 2031F |
6.2.4 Australia Sicca Syndrome Market Revenues & Volume, By Imaging Tests, 2021- 2031F |
6.2.5 Australia Sicca Syndrome Market Revenues & Volume, By Biopsy, 2021- 2031F |
6.2.6 Australia Sicca Syndrome Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Australia Sicca Syndrome Market, By Treatment |
6.3.1 Overview and Analysis |
6.3.2 Australia Sicca Syndrome Market Revenues & Volume, By Medications, 2021- 2031F |
6.3.3 Australia Sicca Syndrome Market Revenues & Volume, By Surgery, 2021- 2031F |
6.3.4 Australia Sicca Syndrome Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Australia Sicca Syndrome Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Australia Sicca Syndrome Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Australia Sicca Syndrome Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4.4 Australia Sicca Syndrome Market Revenues & Volume, By Ocular, 2021- 2031F |
6.4.5 Australia Sicca Syndrome Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Australia Sicca Syndrome Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Australia Sicca Syndrome Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Australia Sicca Syndrome Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 Australia Sicca Syndrome Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Australia Sicca Syndrome Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Australia Sicca Syndrome Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Australia Sicca Syndrome Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Australia Sicca Syndrome Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.6.5 Australia Sicca Syndrome Market Revenues & Volume, By Others, 2021- 2031F |
7 Australia Sicca Syndrome Market Import-Export Trade Statistics |
7.1 Australia Sicca Syndrome Market Export to Major Countries |
7.2 Australia Sicca Syndrome Market Imports from Major Countries |
8 Australia Sicca Syndrome Market Key Performance Indicators |
8.1 Average time to diagnosis of sicca syndrome |
8.2 Number of clinical trials for new treatments of sicca syndrome in Australia |
8.3 Patient satisfaction with currently available treatments |
9 Australia Sicca Syndrome Market - Opportunity Assessment |
9.1 Australia Sicca Syndrome Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Australia Sicca Syndrome Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.3 Australia Sicca Syndrome Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.4 Australia Sicca Syndrome Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Australia Sicca Syndrome Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Australia Sicca Syndrome Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Australia Sicca Syndrome Market - Competitive Landscape |
10.1 Australia Sicca Syndrome Market Revenue Share, By Companies, 2024 |
10.2 Australia Sicca Syndrome Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here